Galmed Pharmaceuticals (GLMD) Change in Cash (2013 - 2026)
Galmed Pharmaceuticals (GLMD) posted quarterly Change in Cash of -$2.4 million for Q1 2026, down 2155.17% year-over-year from $116000.0 in Q1 2025, and down 242.07% quarter-over-quarter from $1.7 million in Q4 2025.
Galmed Pharmaceuticals (GLMD) Change in Cash (2013 - 2026) Analysis & Trends
Galmed Pharmaceuticals' Change in Cash history runs 14 years deep, the most recent figure standing at -$2.4 million for Q1 2026.
- In Q1 2026, Change in Cash fell 2155.17% year-over-year to -$2.4 million; the TTM figure through Mar 2026 stood at -$2.2 million (down 323.99% YoY), while the FY2025 annual figure was $343000.0, up 162.25% from the prior year.
- Change in Cash for Q1 2026 stood at -$2.4 million, down from $1.7 million in the prior quarter.
- The five-year high for Change in Cash was $7.9 million in Q3 2024, with the low at -$7.4 million in Q4 2024.
- The 5-year median for Change in Cash is -$81000.0 (2022), against an average of -$153647.1.
- The sharpest annual moves came in 2024 and 2026: Change in Cash soared 1567.65% in 2024, then slumped 2155.17% in 2026.
- Galmed Pharmaceuticals' Change in Cash stood at -$2.0 million in 2022, then surged by 167.53% to $1.4 million in 2023, then sank by 637.0% to -$7.4 million in 2024, then surged by 122.63% to $1.7 million in 2025, then tumbled by 242.07% to -$2.4 million in 2026.
- Business Quant data shows GLMD's Change in Cash at -$2.4 million in Q1 2026, $1.7 million in Q4 2025, and -$1.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Galmed Pharmaceuticals | 2.31 Mn | -9.57 Mn | - | -2.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.38 Mn |
| Dec 31, 2025 | 1.68 Mn |
| Sep 30, 2025 | -1.65 Mn |
| Jun 30, 2025 | 198,000.00 |
| Mar 31, 2025 | 116,000.00 |
| Dec 31, 2024 | -7.42 Mn |
| Sep 30, 2024 | 7.89 Mn |
| Jun 30, 2024 | 375,000.00 |
| Mar 31, 2024 | -1.40 Mn |
| Dec 31, 2023 | 1.38 Mn |
| Sep 30, 2023 | 473,000.00 |
| Jun 30, 2023 | -662,000.00 |
| Mar 31, 2023 | -344,000.00 |
| Dec 31, 2022 | -2.05 Mn |
| Sep 30, 2022 | 2.08 Mn |
| Jun 30, 2022 | -823,000.00 |
| Mar 31, 2022 | -81,000.00 |
| Dec 31, 2021 | -605,000.00 |
| Sep 30, 2021 | -4.43 Mn |
| Jun 30, 2021 | -5.46 Mn |